Bamco Inc Biogen Inc. Transaction History

Bamco Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $2.21 Million - $3.45 Million	-10,175 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $26,415 - $34,544	90 Added 0.89%	10,175 $3.6 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $1.83 Million - $2.18 Million	-7,108 Reduced 41.34%	10,085 $2.93 Million
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $604,802 - $855,390	2,325 Added 15.64%	17,193 $4.71 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $589,745 - $660,559	1,917 Added 14.8%	14,868 $4.74 Million

Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $3.64 Million - $4.27 Million	12,951	12,951 $4.06 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.